Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Portal Hypertension
In brief
The primary purpose of this study is to determine the efficacy and safety of cobiprostone (at two dose levels) as compared to placebo for lowering portal hypertension.
Key facts
- Study ID
- NCT00737594
- Run by
- Sucampo Pharma Americas, LLC
- People needed
- 9
- Starts
- 2008-07-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2019-11-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is >= 18 years of age.
- Patient has clinical and/or pathological diagnosis of intra-hepatic portal hypertension.
- Patient has clinical diagnosis of cirrhosis.
- Patient has undergone variceal banding.
You may not qualify if…
- Patient has a Child-Pugh score >12.
- Patient has portal hypertension resulting from hepatic vein obstruction, portal vein occlusion, schistosomiasis, portal vein thrombosis, splenic vein thrombosis, or Budd-Chiari syndrome.
- Variceal banding procedure was performed within 1 month of the screening visit.
- Patient has active or recurrent variceal bleeding, or has had variceal bleeding within the 12 weeks prior to screening.
- Patient is unwilling to discontinue use of vasoactive drugs from the screening visit through the end of the study.
- Patient has hepatocellular carcinoma that is being medically treated or is advanced.
- Patient has impaired renal function (i.e., serum creatinine concentration >1.8 mg/dl)
- Patient has a history of liver transplant, or is expected to receive a liver transplant during the study period.
- Patient has undergone a gastrointestinal or abdominal surgical procedure within 90 days prior to the Screening Visit, or has had a bowel resection at any time.
Where it is running
- University of Texas Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.